Amedisys, Inc. (AMED)
USD 84.97
(-0.47%)
USD 84.97
(-0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 137.18 Million | 133.28 Million | 188.89 Million | 288.95 Million | 202 Million | 223.48 Million |
| Net Income | -9.74 Million | 117.69 Million | 210.16 Million | 185.18 Million | 127.9 Million | 120.12 Million |
| Depreciation & Amortization | 23.84 Million | 70.96 Million | 71.26 Million | 67.94 Million | 54.33 Million | 13.26 Million |
| Deferred income taxes | 20.65 Million | 23.37 Million | 44.58 Million | -26.56 Million | 13.46 Million | 20.27 Million |
| Stock-based compensation | 29.02 Million | 16.55 Million | 23.8 Million | 26.73 Million | 35.54 Million | 17.88 Million |
| Change in working capital | -63.2 Million | -105.04 Million | -131.01 Million | 26.22 Million | -31.35 Million | 42.98 Million |
| Other non-cash items | 136.61 Million | 9.72 Million | -29.91 Million | 9.43 Million | 12.61 Million | 8.95 Million |
| Investing Cash Flow | 35.71 Million | -94.48 Million | -281.6 Million | -287.1 Million | -352.94 Million | -22.19 Million |
| Investments in PPE | -12.71 Million | -7.21 Million | -6.72 Million | -5.33 Million | -7.88 Million | -6.55 Million |
| Acquisitions | 48.22 Million | -72.58 Million | -269.96 Million | -281.08 Million | -345.46 Million | -9.26 Million |
| Investment purchases | - | -15 Million | -5.2 Million | -875 Thousand | -210 Thousand | -7.14 Million |
| Sales/Maturities of investments | 150 Thousand | - | -275 Thousand | 80 Thousand | 162 Thousand | 54 Thousand |
| Other Investing Activities | 54 Thousand | 318 Thousand | 554 Thousand | 101 Thousand | 448 Thousand | 715 Thousand |
| Financing Cash Flow | -88.17 Million | -30.43 Million | 55.12 Million | -14.97 Million | 227.2 Million | -267.42 Million |
| Debt repayment | -76.01 Million | -534.5 Million | -551.7 Million | -703.2 Million | -200 Million | -130.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -6.52 Million | -25.33 Million | -116.77 Million | -54.49 Million | -9.55 Million | -187.97 Million |
| Common Stock Issuance | 2.7 Million | 2.3 Billion | 3.96 Billion | 3.56 Billion | 3.18 Billion | 2.42 Million |
| Other Financing Activities | -1.8 Million | -1.77 Billion | 723.6 Million | 742.71 Million | 436.76 Million | 192.57 Million |
| Accounts receivables | -26.72 Million | -14.23 Million | -18.03 Million | 2.11 Million | -24.14 Million | 12.22 Million |
| Accounts payables | -15.81 Million | 4.89 Million | -4.35 Million | 1.94 Million | -11.32 Million | 3.16 Million |
| Inventory | - | - | - | -2.03 Million | 7.11 Million | 22.2 Million |
| Other working capital | -20.66 Million | -95.7 Million | -108.63 Million | 24.2 Million | -3 Million | 5.39 Million |
| Cash at beginning of period | 61.73 Million | 45.76 Million | 83.35 Million | 96.49 Million | 20.22 Million | 86.36 Million |
| Cash at end of period | 145.86 Million | 54.13 Million | 45.76 Million | 83.35 Million | 96.49 Million | 20.22 Million |
| Capital Expenditure | -12.71 Million | -7.21 Million | -6.72 Million | -5.33 Million | -7.88 Million | -6.55 Million |
| Effect of forex changes on cash | -600 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | 84.13 Million | 8.36 Million | -37.58 Million | -13.13 Million | 76.26 Million | -66.13 Million |
| Free Cash Flow | 124.47 Million | 126.06 Million | 182.17 Million | 283.62 Million | 194.11 Million | 216.92 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 32.3 Million | 14.4 Million | 19.32 Million | -9.74 Million | 25.61 Million | -80.48 Million |
| Depreciation & Amortization | 6.35 Million | 14.7 Million | 5.89 Million | 23.84 Million | 14.51 Million | 14.54 Million |
| Deferred income taxes | 3.98 Million | 2.59 Million | 5.23 Million | 20.65 Million | 7.31 Million | 5.33 Million |
| Stock-based compensation | 8.29 Million | 7.88 Million | 9.4 Million | 29.02 Million | 7.24 Million | 9.1 Million |
| Change in working capital | -6.69 Million | -45.83 Million | 12.6 Million | -63.2 Million | -65.07 Million | 12.6 Million |
| Other non-cash items | 36.97 Million | 75.15 Million | 7.85 Million | 136.61 Million | 542 Thousand | 99.64 Million |
| Investing Cash Flow | -1.42 Million | -1.3 Million | -1.81 Million | 35.71 Million | -1.04 Million | -7.74 Million |
| Investments in PPE | -1.57 Million | -2.89 Million | -2.1 Million | -12.71 Million | -1.19 Million | -7.85 Million |
| Acquisitions | 147 Thousand | 1.76 Million | 48.04 Million | 48.22 Million | -46.93 Million | 476 Thousand |
| Investment purchases | - | -196 Thousand | 856 Thousand | - | -856 Thousand | - |
| Sales/Maturities of investments | - | - | -150 Thousand | 150 Thousand | 150 Thousand | - |
| Other Investing Activities | -186 Thousand | 21 Thousand | -47.75 Million | 54 Thousand | 47.78 Million | -370 Thousand |
| Financing Cash Flow | -14.22 Million | -10.31 Million | -13.64 Million | -88.17 Million | -6.25 Million | -10.95 Million |
| Debt repayment | -9.44 Million | -8.94 Million | -8.9 Million | -76.01 Million | -9.33 Million | -15 Million |
| Dividends payments | - | - | -25.71 Million | - | - | - |
| Common Stock Repurchased | -3.57 Million | -617 Thousand | -2.11 Million | -6.52 Million | -925 Thousand | -2.18 Million |
| Common Stock Issuance | - | - | - | 2.7 Million | 848 Thousand | 938 Thousand |
| Other Financing Activities | -4.78 Million | -1.37 Million | -2.62 Million | -1.8 Million | 12.49 Million | 20.36 Million |
| Accounts receivables | 2.44 Million | -46.8 Million | 6.2 Million | -26.72 Million | -40.79 Million | 15.33 Million |
| Accounts payables | -10.34 Million | 8.65 Million | -6.97 Million | -15.81 Million | -4.1 Million | -1.27 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.19 Million | -7.67 Million | 13.37 Million | -20.66 Million | 44.9 Million | -14.06 Million |
| Cash at beginning of period | 120.7 Million | 145.86 Million | 94.01 Million | 61.73 Million | 111.16 Million | 69.1 Million |
| Cash at end of period | 157.35 Million | 120.7 Million | 145.86 Million | 145.86 Million | 94.01 Million | 111.16 Million |
| Capital Expenditure | -1.57 Million | -2.89 Million | -2.1 Million | -12.71 Million | -1.19 Million | -7.85 Million |
| Effect of forex changes on cash | - | - | 7 Million | -600 Thousand | - | - |
| Net cash flow / Change in cash | 36.65 Million | -25.15 Million | 51.84 Million | 84.13 Million | -17.14 Million | 42.06 Million |
| Free Cash Flow | 50.73 Million | -9.43 Million | 58.2 Million | 124.47 Million | -11.04 Million | 52.9 Million |
4262
2120
0855
PPAAY
SLARL
6249